Adelphi Research Post Cycle Therapy 40mg (100 Tablets)

Adelphi Research Post Cycle Therapy 40mg (100 Tablets) is a comprehensive multi-agent oral formulation designed for research studies involving hormonal recovery modelling, endocrine rebalance, restoration of baseline function, and post-cycle modulation pathways. This PCT blend contains four well-known research compounds:

• Nolvadex (Tamoxifen) – 10mg

• Clomid (Clomiphene Citrate) – 25mg

• Proviron (Mesterolone) – 2.5mg

• Cialis (Tadalafil) – 2.5mg

The combination is frequently referenced in studies examining selective estrogen receptor modulation, androgen support, libido restoration, and physiological homeostasis following high-output performance cycles.

Researchers use this multi-compound structure to observe post-cycle endocrine behaviour, hormone optimisation patterns, libido and performance variables, and potential mood or energy stabilisation effects during recovery-phase modelling.

Key Research Features

Nolvadex (10mg)

Referenced for:

• Modulation of estrogen receptor activity

• Supportive hormonal rebalance during post-cycle phases

Clomid (25mg)

Studied for:

• Endocrine response stimulation

• Post-cycle hormonal activity modelling

Proviron (2.5mg)

Examined for:

• Androgenic pathway support

• Improved performance markers during post-cycle studies

Cialis (2.5mg)

Included to:

• Support vascular and performance-related pathways

• Help stabilise post-cycle physiological responses

Tablet Strength & Appearance

• Potency: 40mg per tablet

• Appearance: Rounded white tablet with centre split

• Quantity: 100 tablets per pack

How to Use (Research Reference Only)

Research modelling commonly references:

• 40mg–80mg per day depending on observation duration and study structure.

This is not guidance for human use — scientific context only.

Stacking (Research Context)

In experimental environments, Adelphi PCT is often examined on its own following performance cycles.
In some study designs, researchers assess interactions with:

• Aromatase inhibitors

• Androgen-support models

• Hormonal regulation compounds

Stacking varies depending on study objectives.

Summary

Adelphi Research Post Cycle Therapy 40mg is a multi-compound oral research product designed for laboratory investigations involving hormonal rebalancing, endocrine recovery models, libido and mood stabilisation pathways, and performance-restoration simulations following high-output cycles. Its four-agent blend allows broad-spectrum modelling across several physiological pathways.

Research Use Disclaimer

For laboratory and scientific research use only.
Not intended for human consumption, medical treatment, or veterinary application.